HCV Support's
Donation Drive 2012.
Help HCV Support in continuing it's mission of providing knowledge, support and encouragement to those affected by hepatitis C.

Fundraising Thermometer
Donate Now!
Many thanks to all our current HCV Support Donors:
  • B
  • banarep
  • Cali
  • Donna
  • DougV
  • firefly326
  • Frank
  • gale
  • glee
  • greyrocker
  • jimmer
  • justme
  • LivinLife
  • Marijean
  • ole44
  • p.hat
  • Rattler
  • relay
  • Rocky
  • ruba
  • rwe1949
  • sista sue
  • Steph
  • sweetsue
  • welshchef

The Grey Banana Shoutbox


« previous next »
Pages: [1]   Go Down

Author Topic: [Bing]- UPDATE: Phase 2b Study Demonstrates GlobeImmune's GI-5005 HCV Therapeutic Vaccine Increases ... - msnbc.com  (Read 452 times)

Offline Viper

  • Hepatitic Dragon Slayer
  • Chief Administrator
  • Paladin
  • *
  • Posts: 829
  • Gender: Male
  • HCV Genotype: 2b
  • Treatment Therapy Success: Undetectable
[Bing]- UPDATE: Phase 2b Study Demonstrates GlobeImmune's GI-5005 HCV Therapeutic Vaccine Increases ... - msnbc.com
« on: November 07, 2010, 07:00:35 PM »
UPDATE: Phase 2b Study Demonstrates GlobeImmune's GI-5005 HCV Therapeutic Vaccine Increases ... - msnbc.com

The improved HCV-specific T cell immunity in IL28B T/T patients receiving ... For additional information, please visit the company's website at www.globeimmune.com. This news release and the anticipated presentation contain forward-looking statements that ...

http://www.msnbc.msn.com/id/39924901
Logged
Pages: [1]   Go Up
« previous next »
 

Information provided in this site is solely for educational purposes only and is intended to support, not replace, the relationship that exists between a patient and their physician. HCV Support .org / HCV Support, Inc. does not provide medical advice nor endorse any Physicians or Pharmaceutical companies mentioned within the Site. Always consult with your HEALTHCARE PROVIDER regarding all aspects of managing and/or treating your HCV, or any other health related issues you may have.